Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
RMD Open|December 29, 2022
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational studyAlberto Floris, Elisabetta Chessa, Gian Domenico Sebastiani, et al.Clinical and Experimental Rheumatology|April 29, 2022
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentationChiara Tani, Elena Elefante, Laurent Arnaud, et al.Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.Journal of Nephrology|January 30, 2025
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohortGrazia Dea Bonelli, Savino Sciascia, Marta Calatroni, et al.The Journal of Rheumatology|January 15, 2023
Patient Care Pathways for Pregnancy in Rare and Complex Rheumatic Diseases: Results From an International SurveyChiara Tani, Dina Zucchi, Elisa Bellis, et al.Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.Annals of the Rheumatic Diseases|March 6, 2026
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatmentSofia Papanikolaou, Evgenia Emmanouilidou, Christina Adamichou, et al.Clinical and Experimental Rheumatology|January 24, 2020
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosusImmacolata Prevete, Gerard Espinosa, Francesca Bellisai, et al.The Journal of Rheumatology|July 1, 2024
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter StudyChiara Tani, Chiara Cardelli, Margherita Zen, et al.Pageof 16